Who owns LENZ THERAPEUTICS INC?
- Ticker: LENZ
- CUSIP Number: 52635n103
Tip: Access positions for across all investors
Analyze quarterly positions in Lenz Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lenz Therapeutics stock
Who bought or sold LENZ THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 4.2M | $72M | 0% | Jun 2024 |
|
| Falcon Edge Capital | 3.6M | $63M | 0% | Jun 2024 |
|
| EcoR1 Capital | 1.2M | $21M | 0% | Jun 2024 |
|
| Samsara BioCapital | 1.2M | $21M | 0% | Jun 2024 |
|
| Sectoral Asset Management | 1.1M | $24M | 100% | Mar 2024 |
|
| 72 Investment Holdings | 1.0M | $18M | 0% | Jun 2024 |
|
| BlackRock | 960k | $17M | 298% | Jun 2024 |
|
| Vanguard Group | 956k | $17M | 362% | Jun 2024 |
|
| Point72 Asset Management | 865k | $15M | 0% | Jun 2024 |
|
| Rtw Investments | 863k | $19M | 100% | Mar 2024 |
|
| Tang Capital Management | 748k | $13M | 37% | Jun 2024 |
|
| Geode Capital Management | 360k | $6.2M | 308% | Jun 2024 |
|
| Alyeska Investment Group | 322k | $5.6M | 61% | Jun 2024 |
|
| State Street Corporation | 244k | $4.2M | 274% | Jun 2024 |
|
| Ikarian Capital | 205k | $3.5M | 141% | Jun 2024 |
|
| Board of Trustees of The Leland Stanford Junior University | 100k | $1.7M | 0% | Jun 2024 |
|
| Wealth Enhancement Advisory Services | 83k | $1.4M | 100% | Jun 2024 |
|
| Morgan Stanley | 66k | $1.1M | 143% | Jun 2024 |
|
| Prosight Management | 65k | $1.5M | 100% | Mar 2024 |
|
| BML Capital Management | 64k | $1.1M | 0% | Jun 2024 |
|
| Renaissance Technologies | 60k | $1.0M | 28% | Jun 2024 |
|
| Vivaldi Capital Management | 59k | $1.0M | 0% | Jun 2024 |
|
| Charles Schwab Investment Management | 42k | $717k | 255% | Jun 2024 |
|
| Northern Trust | 41k | $908k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 40k | $687k | 255% | Jun 2024 |
|
| Dimensional Fund Advisors | 37k | $643k | 58% | Jun 2024 |
|
| Two Sigma Investments | 34k | $593k | 100% | Jun 2024 |
|
| Nuveen Asset Management | 23k | $400k | 100% | Jun 2024 |
|
| Jump Financial | 23k | $391k | 100% | Jun 2024 |
|
| Boothbay Fund Management | 23k | $505k | 100% | Mar 2024 |
|
| Marshall Wace | 23k | $390k | 100% | Jun 2024 |
|
| Bridgeway Capital Management | 22k | $379k | 0% | Jun 2024 |
|
| BBR Partners | 20k | $346k | 100% | Jun 2024 |
|
| Citigroup | 19k | $319k | 2362% | Jun 2024 |
|
| Deerfield Management Company | 17k | $300k | 100% | Jun 2024 |
|
| Rhumbline Advisers | 17k | $291k | 266% | Jun 2024 |
|
| Bank of America Corporation | 17k | $289k | 325% | Jun 2024 |
|
| Bnp Paribas Arbitrage, Snc | 17k | $285k | 2% | Jun 2024 |
|
| Engineers Gate Manager | 15k | $253k | 100% | Jun 2024 |
|
| Goldman Sachs Group | 13k | $229k | 100% | Jun 2024 |
|
| Squarepoint Ops | 11k | $181k | 100% | Jun 2024 |
|
| Wells Fargo & Company | 5.6k | $98k | 316% | Jun 2024 |
|
| Jpmorgan Chase & Co | 5.4k | $94k | 222% | Jun 2024 |
|
| Deutsche Bank Aktiengesellschaft | 5.3k | $92k | 100% | Jun 2024 |
|
| Barclays | 4.4k | $76k | -33% | Jun 2024 |
|
| UBS Group | 4.3k | $95k | 100% | Mar 2024 |
|
| New York State Common Retirement Fund | 3.5k | $60k | 0% | Jun 2024 |
|
| Mirae Asset Global Etfs Holdings | 1.6k | $28k | 100% | Jun 2024 |
|
| FMR | 1.4k | $31k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 1.3k | $25k | 1343% | Jun 2024 |
|
| Summit Investment Advisors | 1.2k | $21k | 272% | Jun 2024 |
|
| California State Teachers Retirement System | 910.00 | $16k | 100% | Jun 2024 |
|
| Tower Research Capital | 866.00 | $15k | 92% | Jun 2024 |
|
| Legal & General Group | 382.00 | $8.5k | 100% | Mar 2024 |
|
| Amalgamated Bank | 135.00 | $2.0k | 0% | Jun 2024 |
|
| GAMMA Investing | 31.00 | $535.999300 | 100% | Jun 2024 |
|
| Federation des caisses Desjardins du Quebec | 28.00 | $483.999600 | 0% | Jun 2024 |
|
| Russell Investments | 13.00 | $225.000100 | 100% | Jun 2024 |
|
| Lazard Asset Management | 12.00 | $0 | -96% | Jun 2024 |
|
| SRS Capital Advisors | 12.00 | $207.999600 | 100% | Jun 2024 |
|
| CWM | 8.00 | $0 | 100% | Jun 2024 |
|
| Advisor Group Holdings | 2.00 | $45.000000 | 100% | Mar 2024 |
|
Who sold out of Lenz Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jennison Associates | Mar 2024 | 135k | $3.0M |
| Jacobs Levy Equity Management | Mar 2024 | 37k | $830k |
| Acuitas Investments | Mar 2024 | 32k | $703k |
| CornerCap Investment Counsel | Mar 2024 | 9.4k | $209k |
| Marquette Asset Management | Mar 2024 | 5.9k | $131k |
| American International | Mar 2024 | 2.0k | $44k |
| Qube Research & Technologies | Mar 2024 | 982.00 | $22k |
| NISA Investment Advisors | Mar 2024 | 644.00 | $14k |
| Group One Trading | Mar 2024 | 571.00 | $13k |